The chromosome 15q14 locus for bipolar disorder and schizophrenia: Is C15orf53 a major candidate gene?

Journal of Psychiatric Research

Volumn 46, Issue 11, 2012, Pages 1414-1420

  Kranz, Thorsten M ^a   Ekawardhani, Savira ^a   Lin, Michelle K ^a   Witzmann, Simone R ^a,b   Streit, Fabian ^a,c   Schuelter, Ulrike ^a   Bauer, Hans ^a   Henseler, Darja ^a   Turner, Jonathan D ^a,b   Muller, Claude P ^a,b   Reif, Andreas ^d   Schote, Andrea B ^a   Meyer, Jobst ^a  

^a UNIVERSITY OF TRIER   (Germany)

^b LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^c CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Bipolar disorder; C15orf53; Gene expression; Periodic catatonia; Schizophrenia; Segregation

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; AUTOPSY; AUTOSOME; BIPOLAR DISORDER; C15ORF53 GENE; CATATONIA; CHROMOSOME 15Q14; CONTROLLED STUDY; GENE; GENE EXPRESSION PROFILING; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPING TECHNIQUE; HAPLOTYPE; HUMAN; HUMAN TISSUE; LIMBIC CORTEX; MICROSATELLITE MARKER; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CATATONIA; CHROMOSOMES, HUMAN, PAIR 15; FEMALE; GENETIC LINKAGE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; OPEN READING FRAMES; SCHIZOPHRENIA;

EID: 84866927603     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.08.008     Document Type: Article

References (56)

1. Alt S.R., Turner J.D., Klok M.D., Meijer O.C., Lakke E.A.J.F., DeRijk R.H., et al. Differential expression of glucocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed. Psychoneuroendocrinology 2010, 35(4):544-556.
2. Attarbaschi T., Sacher J., Geiss-Granadia T., Klein N., Mossaheb N., Lanzenberger R., et al. Striatal D(2) receptor occupancy in bipolar patients treated with olanzapine. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 2007, 17(2):102-107.
3. Beckmann H., Franzek E., Stober G. Genetic heterogeneity in catatonic schizophrenia: a family study. American Journal of Medical Genetics 1996, 67(3):289-300. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8725746.
4. Bellivier F., Golmard J., Rietschel M., Schulze T.G., Malafosse A., Preisig M., et al. Age at onset in bipolar I affective disorder: further evidence for three subgroups. The American Journal of Psychiatry 2003, 160(5):999-1001.
5. Ben-Shachar S., Lanpher B., German J.R., Qasaymeh M., Potocki L., Nagamani S.C., et al. Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders. Journal of Medical Genetics 2009, 46(6):382-388. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1136/jmg.2008.064378.
6. Binder E.B., Salyakina D., Lichtner P., Wochnik G.M., Ising M., Putz B., et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nature Genetics 2004, 36(12):1319-1325.
7. Chagnon Y.C. Shared chromosomal susceptibility regions between autism and other mental disorders. International Review of Neurobiology 2005, 71:419-443. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16512360.
8. Collier D.A., Arranz M.J., Sham P., Battersby S., Vallada H., Gill P., et al. The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. NeuroReport 1996, 7(10):1675-1679.
9. Craddock N., Lendon C. Chromosome workshop: chromosomes 11, 14, and 15. American Journal of Medical Genetics 1999, 88(3):244-254. 10.1002/(SICI)1096-8628(19990618)88:3<244:AID-AJMG7>3.0.CO;2-1 [pii]. http://www.ncbi.nlm.nih.gov/pubmed/.
10. Craddock N., O'Donovan M.C., Owen M.J. The genetics of schizophrenia and bipolar disorder: dissecting psychosis. Journal of Medical Genetics 2005, 42(3):193-204. http://jmg.bmj.com/cgi/content/abstract/42/3/193.
11. Dezso Z., Nikolsky Y., Sviridov E., Shi W., Serebriyskaya T., Dosymbekov D., et al. A comprehensive functional analysis of tissue specificity of human gene expression. BMC Biology 2008, 6:49.
12. Dykens E.M., Sutcliffe J.S., Levitt P. Autism and 15q11-q13 disorders: behavioral, genetic, and pathophysiological issues. Mental Retardation and Developmental Disabilities Research Reviews 2004, 10(4):284-291.
13. Ekici A. Periodic catatonia: systematic analysis of candidate genes in a schizophrenia locus on chromosome 15q15. European Journal of Human Genetics 2004, 282:12.
14. Fallin M.D., Lasseter V.K., Avramopoulos D., Nicodemus K.K., Wolyniec P.S., McGrath J.A., et al. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. American Journal of Human Genetics 2005, 77(6):918-936. S0002-9297(07)63378-3 [pii]. http://www.ncbi.nlm.nih.gov/pubmed/.
15. Ferreira M.A.R., O'Donovan M.C., Meng Y.A., Jones I.R., Ruderfer D.M., Jones L., et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nature Genetics 2008, 40(9):1056-1058.
16. Gawlik M., Moller-Ehrlich K., Mende M., Jovnerovski M., Jung S., Jabs B., et al. Is FKBP5 a genetic marker of affective psychosis? A case control study and analysis of disease related traits. BMC Psychiatry 2006, 6:52.
17. Granger B., Albu S. The haloperidol story. Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists 2005, 17(3):137-140.
18. Hashimoto K. Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry and Clinical Neurosciences 2010, 64(4):341-357.
19. Kimura K., Wakamatsu A., Suzuki Y., Ota T., Nishikawa T., Yamashita R., et al. Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. Genome Research 2006, 16(1):55-65.
20. Knight H.M., Pickard B.S., Maclean A., Malloy M.P., Soares D.C., McRae A.F., et al. A cytogenetic abnormality and rare coding variants identify ABCA13 as a candidate gene in schizophrenia, bipolar disorder, and depression. American Journal of Human Genetics 2009, 85(6):833-846.
21. Leonhard K., Beckmann H. Classification of endogenous psychoses and their differential etiology 1999, Springer, Wien, New York.
22. Lewis C.M., Levinson D.F., Wise L.H., DeLisi L.E., Straub R.E., Hovatta I., et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. American Journal of Human Genetics 2003, 73(1):34-48. S0002-9297(07)63893-2 [pii]. http://www.ncbi.nlm.nih.gov/pubmed/.
23. Linnoila M., Karoum F., Potter W.Z. Effects of antidepressant treatments on dopamine turnover in depressed patients. Archives of General Psychiatry 1983, 40(9):1015-1017.
24. Liu Y., Blackwood D.H., Caesar S., de Geus E.J., Farmer A., Ferreira M.A., et al. Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Molecular Psychiatry 2011, 16(1):2-4.
25. Manolio T.A., Collins F.S. The HapMap and genome-wide association studies in diagnosis and therapy. Annual Review of Medicine 2009, 60:443-456.
26. McClellan J., King M.C. Genetic heterogeneity in human disease. Cell 2010, 141(2):210-217.
27. McGuffin P., Owen M.J., Farmer A.E. Genetic basis of schizophrenia. Lancet 1995, 346(8976):678-682. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7658823.
28. McGuffin P., Perroud N., Uher R., Butler A., Aitchison K.J., Craig I., et al. The genetics of affective disorder and suicide. European Psychiatry: The Journal of the Association of European Psychiatrists 2010, 25(5):275-277.
29. Meyer J., Huberth A., Ortega G., Syagailo Y.V., Jatzke S., Mossner R., et al. A missense mutation in a novel gene encoding a putative cation channel is associated with catatonic schizophrenia in a large pedigree. Molecular Psychiatry 2001, 6(3):302-306. PM:11326298.
30. Meyer J., Ortega G., Schraut K., Nurnberg G., Ruschendorf F., Saar K., et al. Exclusion of the neuronal nicotinic acetylcholine receptor alpha7 subunit gene as a candidate for catatonic schizophrenia in a large family supporting the chromosome 15q13-22 locus. Molecular Psychiatry 2002, 7(2):220-223. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1038/sj.mp.4000970.
31. Meyer J., Ruschendorf F., Lesch K.P. A second large family with catatonic schizophrenia supports the region distally of CHRNA7 on chromosome 15q14-15. Molecular Psychiatry 2003, 8(3):259-260. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1038/sj.mp.4001222.
32. Meyer J., Johannssen K., Freitag C.M., Schraut K., Teuber I., Hahner A., et al. Rare variants of the gene encoding the potassium chloride co-transporter 3 are associated with bipolar disorder. International Journal of Neuropsychopharmacology 2005, 8(4):495-504. PM:16098236.
33. Middlemiss D.N., Price G.W., Watson J.M. Serotonergic targets in depression. Current Opinion in Pharmacology 2002, 2(1):18-22.
34. Nothen M.M., Nieratschker V., Cichon S., Rietschel M. New findings in the genetics of major psychoses. Dialogues in Clinical Neuroscience 2010, 12(1):85-93.
35. Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., et al. Complete sequencing and characterization of 21,243 full-length human cDNAs. Nature Genetics 2003, 36(1):40-45.
36. Perälä J., Suvisaari J., Saarni S.I., Kuoppasalmi K., Isometsä E., Pirkola S., et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Archives of General Psychiatry 2007, 64(1):19-28.
37. Potash J.B., DePaulo J.R. Searching high and low: a review of the genetics of bipolar disorder. Bipolar Disorders 2000, 2(1):8-26. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11254025.
38. Reif A., Herterich S., Strobel A., Ehlis A., Saur D., Jacob C.P., et al. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Molecular Psychiatry 2006, 11(3):286-300.
39. Riley B.P., Makoff A., Mogudi-Carter M., Jenkins T., Williamson R., Collier D., et al. Haplotype transmission disequilibrium and evidence for linkage of the CHRNA7 gene region to schizophrenia in Southern African Bantu families. American Journal of Medical Genetics 2000, 96(2):196-201.
40. Rozen S., Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods in Molecular Biology (Clifton, N.J.) 2000, 132:365-386.
41. Saha S., Chant D., Welham J., McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Medicine 2005, 2(5):e141.
42. Selch S., Strobel A., Haderlein J., Meyer J., Jacob C.P., Schmitt A., et al. MLC1 polymorphisms are specifically associated with periodic catatonia, a subgroup of chronic schizophrenia. Biological Psychiatry 2007, 61(10):1211-1214.
43. Smith E.N., Bloss C.S., Badner J.A., Barrett T., Belmonte P.L., Berrettini W., et al. Genome-wide association study of bipolar disorder in European American and African American individuals. Molecular Psychiatry 2009, 14(8):755-763. http://www.nature.com/mp/journal/v14/n8/suppinfo/mp200943s1.html.
44. Smoller J.W., Finn C.T. Family, twin, and adoption studies of bipolar disorder. American Journal of Medical Genetics 2003, 123C(1):48-58.
45. St Clair D., Blackwood D., Muir W., Carothers A., Walker M., Spowart G., et al. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 1990, 336(8706):13-16. 0140-6736(90)91520-K [pii]. http://www.ncbi.nlm.nih.gov/pubmed/.
46. Stober G., Franzek E., Lesch K.P., Beckmann H. Periodic catatonia: a schizophrenic subtype with major gene effect and anticipation. European Archives of Psychiatry and Clinical Neuroscience 1995, 245(3):135-141.
47. Stober G., Saar K., Ruschendorf F., Meyer J., Nurnberg G., Jatzke S., et al. Splitting schizophrenia: periodic catatonia-susceptibility locus on chromosome 15q15. American Journal of Human Genetics 2000, 67(5):1201-1207. PM:11001582.
48. Stober G., Pfuhlmann B., Nurnberg G., Schmidtke A., Reis A., Franzek E., et al. Towards the genetic basis of periodic catatonia: pedigree sample for genome scan I and II. European Archives of Psychiatry and Clinical Neuroscience 2001, 251(Suppl. 1):I25-I30. PM:11776268.
49. Stober G., Seelow D., Ruschendorf F., Ekici A., Beckmann H., Reis A. Periodic catatonia: confirmation of linkage to chromosome 15 and further evidence for genetic heterogeneity. Human Genetics 2002, 111(4-5):323-330. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1007/s00439-002-0805-4.
50. Strausberg R.L., Feingold E.A., Grouse L.H., Derge J.G., Klausner R.D., Collins F.S., et al. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(26):16899-16903.
51. Sullivan P.F., Kendler K.S., Neale M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Archives of General Psychiatry 2003, 60(12):1187-1192. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1001/archpsyc.60.12.1187.
52. Sutcliffe J.S., Nakao M., Christian S., Orstavik K.H., Tommerup N., Ledbetter D.H., et al. Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nature Genetics 1994, 8(1):52-58.
53. Taylor M.A., Fink M. Catatonia in psychiatric classification: a home of its own. American Journal of Psychiatry 2003, 160(7):1233-1241. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12832234.
54. Tsuang M.T. The genetics of mood disorders 1990, Johns Hopkins University Press, Baltimore.
55. Turecki G., Grof P., Grof E., D'Souza V., Lebuis L., Marineau C., et al. Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium. Molecular Psychiatry 2001, 6(5):570-578. http://www.ncbi.nlm.nih.gov/pubmed/, 10.1038/sj.mp.4000888.
56. Verma R., Chauhan C., Saleem Q., Gandhi C., Jain S., Brahmachari S.K. A nonsense mutation in the synaptogyrin 1 gene in a family with schizophrenia. Biological Psychiatry 2004, 55(2):196-199.